GILEAD SCIENCES, INC. - 07 Jan 2025 SCHEDULE 13D/A Report for Galapagos NV Ordinary Shares, no par value (GLPG)

Filing Manager
GILEAD SCIENCES, INC.
Reporting Manager
Gilead Sciences, Inc.
Security
Galapagos NV Ordinary Shares, no par value
Symbol
GLPG
Shares outstanding
70,170,602 shares
Disclosed Ownership
20,981,010 shares
Ownership
29.9%
Form type
SCHEDULE 13D/A
Filing time
10 Jan 2025, 15:46:26 UTC
Date of event
07 Jan 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Gilead Sciences, Inc. 29.9% 20,981,010 0 20,981,010 /s/ Andrew D. Dickinson Andrew D. Dickinson, Executive Vice President and Chief Financial Officer 0000882095
Gilead Therapeutics A1 Unlimited Company 29.9% 20,981,010 0 20,981,010 /s/ Aoife Marrinan Aoife Marrinan, Director